S'identifier

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.

These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads to their internalization and degradation; and by inducing the breakdown of the postsynaptic muscle membrane. This results in impaired neurotransmission, leading to drooping eyelids, double vision, difficulty swallowing (dysphagia), and speech difficulties (dysarthria). In severe cases, respiratory and limb muscles may also be affected.

The primary drugs used to manage the symptoms of myasthenia gravis are acetylcholinesterase (AChE) inhibitors. These include neostigmine, pyridostigmine, and ambenonium. These medications help increase the accumulation of acetylcholine in the synaptic cleft, which assists in depolarizing the endplate and improving muscle function. Thymectomy, the surgical removal of the thymus gland, is often recommended due to its potential role in the disease's development and the frequent presence of thymus gland tumors. Thymectomy can gradually improve motor symptoms and sometimes lead to complete remission. In severe cases, plasmapheresis may be necessary to remove circulating antibodies. Immunosuppressant medications such as azathioprine, cyclosporine, and glucocorticoids are used to target T-cells and reduce the production of anti-receptor antibodies, providing clinical benefits.

Tags

Myasthenia GravisNeuromuscular Transmission DisorderAutoimmune DiseaseAcetylcholine ReceptorsAntibodiesNeurotransmission ImpairmentDrooping EyelidsDouble VisionDysphagiaDysarthriaAcetylcholinesterase InhibitorsNeostigminePyridostigmineAmbenoniumThymectomyPlasmapheresisImmunosuppressants

Du chapitre 5:

article

Now Playing

5.17 : Myasthenia Gravis: Overview and Treatment

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

926 Vues

article

5.1 : Système nerveux autonome : aperçu

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

3.5K Vues

article

5.2 : Transmission neurochimique : sites d’action du médicament

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

1.9K Vues

article

5.3 : Classification des neurotransmetteurs

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

2.4K Vues

article

5.4 : Neurones cholinergiques : Neurotransmission

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

2.3K Vues

article

5.5 : Récepteurs cholinergiques : Muscariniques

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

1.4K Vues

article

5.6 : Récepteurs cholinergiques : nicotiniques

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

1.9K Vues

article

5.7 : Agonistes cholinergiques à action directe : chimie et relation structure-activité

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

704 Vues

article

5.8 : Agonistes cholinergiques à action directe : pharmacocinétique

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

963 Vues

article

5.9 : Agonistes cholinergiques à action directe : actions pharmacologiques

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

1.1K Vues

article

5.10 : Agonistes cholinergiques à action directe : utilisations thérapeutiques

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

581 Vues

article

5.11 : Cholinestérases : distribution et fonction

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

351 Vues

article

5.12 : Agonistes cholinergiques à action indirecte : chimie et relation structure-activité

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

445 Vues

article

5.13 : Agonistes cholinergiques à action indirecte : mécanisme d’action

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

1.4K Vues

article

5.14 : Agonistes cholinergiques à action indirecte : pharmacocinétique

Drugs Acting on Autonomic Nervous System: Cholinergic Agonists and Antagonists Agents

837 Vues

See More

JoVE Logo

Confidentialité

Conditions d'utilisation

Politiques

Recherche

Enseignement

À PROPOS DE JoVE

Copyright © 2025 MyJoVE Corporation. Tous droits réservés.